Optimizerx Corp (OPRX) Stock Price, Quote & News

Company Profile

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribu...

Industry: Health Information Services

Sector: Healthcare

Phone: 248 651 6568

Website: www.optimizerx.com

Address:

260 Charles Street, Suite 302, Waltham, United States

Maissessap May. 13 at 1:44 PM

$OPRX Very well deserved drop ! Management bunch of liars.

0 · Reply

Bennettp22 May. 13 at 12:33 PM

$OPRX swing pop!! Oh yeah…

0 · Reply

MarketBeat May. 13 at 2:08 AM

https://marketbeat.com/a/8651228/ $OPRX OptimizeRx Q1 Earnings Call Highlights

0 · Reply

EarningsInsider May. 12 at 9:32 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-optimizerx-co-stock/ $OPRX OptimizeRx Earnings Transcript

0 · Reply

Olivia_Strickland May. 12 at 9:09 PM

$OPRX down 7.73% AH after the Q1 print and a guidance update, because nothing says 'great quarter' like the company quietly rewriting the rest of the year a few hours later. already 53% in the hole YTD and the tape's still finding new lows to poke at. the real story isn't in the headline beat, it's in what they did to the outlook a few lines down. who actually read the release, what's the line that moved this? the guide miss the tape didn't like: https://tapeboard.com/chart/OPRX?utm_source=stocktwits&utm_medium=post&utm_campaign=olivia&utm_content=oprx-ah-dn-miss

0 · Reply

Bennettp22 May. 12 at 8:45 PM

$OPRX when will I learn ….

0 · Reply

brd03 May. 12 at 8:14 PM

$OPRX earnings today??

0 · Reply

StocktwitsEarnings May. 12 at 8:14 PM

$OPRX Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.03 up 75.00% YoY • Reported revenue of $19.84M down -9.50% YoY • OptimizeRx updated its fiscal year 2026 guidance, now expecting revenue of $95M to $100M and adjusted EBITDA of $21M to $25M for the year.

0 · Reply

MuesLee May. 12 at 7:58 PM

$OPRX $RILY $SKLZ $VELO picked oprx

1 · Reply

MuesLee May. 12 at 7:40 PM

$VELO $RILY $SKLZ $OPRX What to buy out of these four before close ... undecided yet, expect each of them to bounce and revert.

0 · Reply

OptimizeRx price target lowered to $11 from $20 at Lake Street

2026-05-13T14:04:14.000Z - 1 hour ago

OptimizeRx price target lowered to $10 from $11 at B. Riley

2026-05-13T12:27:39.000Z - 3 hours ago

OptimizeRx price target lowered to $7 from $10 at Stephens

2026-05-13T11:31:03.000Z - 4 hours ago

OptimizeRx price target lowered to $14 from $17 at Stifel

2026-05-12T22:14:39.000Z - 17 hours ago

OptimizeRx reports Q1 EPS 14c, consensus 0c

2026-05-12T22:07:44.000Z - 17 hours ago

OptimizeRx cuts FY26 revenue view to $95M-$100M from $109M-$114M

May 12, 2026, 4:30 PM EDT - 19 hours ago

OptimizeRx Earnings Call Transcript: Q1 2026

May 12, 2026, 4:01 PM EDT - 19 hours ago

OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance

May 11, 2026, 7:30 AM EDT - 2 days ago

OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale

Apr 29, 2026, 4:05 PM EDT - 13 days ago

OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report

Apr 28, 2026, 8:00 AM EDT - 15 days ago

OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET

Apr 8, 2026, 4:05 PM EDT - 4 weeks ago

OptimizeRx Appoints Mary Varghese Presti to Board of Directors

2026-03-06T14:46:41.000Z - 2 months ago

OptimizeRx trading resumes

2026-03-06T14:37:18.000Z - 2 months ago

OptimizeRx trading halted, volatility trading pause

2026-03-06T13:42:38.000Z - 2 months ago

OptimizeRx price target lowered to $20 from $24 at Lake Street

2026-03-06T13:36:56.000Z - 2 months ago

OptimizeRx price target lowered to $11 from $28 at B. Riley

2026-03-06T12:55:55.000Z - 2 months ago

OptimizeRx price target lowered to $18 from $32 at Roth Capital

2026-03-06T12:27:10.000Z - 2 months ago

OptimizeRx price target lowered to $17 from $21 at Stifel

2026-03-06T11:50:10.000Z - 2 months ago

OptimizeRx price target lowered to $10 from $17 at Stephens

Mar 5, 2026, 5:04 PM EST - 2 months ago

UPDATE – OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

Mar 5, 2026, 4:30 PM EST - 2 months ago

OptimizeRx Earnings Call Transcript: Q4 2025

2026-03-05T21:11:34.000Z - 2 months ago

OptimizeRx reports Q4 EPS 51c, consensus 22c

2026-03-05T21:11:02.000Z - 2 months ago

OptimizeRx sees FY26 revenue $109M-$114M, consensus $121.63M

2026-03-05T21:10:39.000Z - 2 months ago

OptimizeRx announces $10M share repurchase program

Mar 5, 2026, 4:01 PM EST - 2 months ago

OptimizeRx Reports Strong Fourth Quarter and Full Year 2025 Financial Results

2026-03-04T15:21:04.000Z - 2 months ago

OptimizeRx management to meet with Lake Street

Feb 5, 2026, 8:00 AM EST - 3 months ago

OptimizeRx Sets Fourth Quarter and Full Year 2025 Financial Results Conference Call for March 5, 2026, at 4:30 p.m. ET

2026-01-07T13:12:04.000Z - 4 months ago

OptimizeRx announces data collaboration with Experian

Jan 7, 2026, 8:00 AM EST - 4 months ago

OptimizeRx and Experian Collaborate to Improve Privacy-Safe Identity Resolution in Healthcare Marketing

2025-12-17T10:15:33.000Z - 5 months ago

OptimizeRx announces four new partner agreements

Dec 17, 2025, 4:30 AM EST - 5 months ago

OptimizeRx Continues Expansion of the Company's Point-Of-Care Network

2025-11-17T12:20:07.000Z - 6 months ago

OptimizeRx price target lowered to $17 from $20 at Stephens

Nov 6, 2025, 4:30 PM EST - 6 months ago

OptimizeRx Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:01 PM EST - 6 months ago

OptimizeRx Reports Third Quarter 2025 Financial Results and Increases Fiscal Year 2025 Guidance

Oct 20, 2025, 8:00 AM EDT - 7 months ago

OptimizeRx Sets Third Quarter 2025 Conference Call for November 6, 2025, at 4:30 p.m. ET

Sep 10, 2025, 7:30 AM EDT - 8 months ago

OptimizeRx to Participate in the 9th Annual Lake Street Capital Best Ideas Growth Conference

Sep 9, 2025, 4:05 PM EDT - 8 months ago

OptimizeRx Partners with Lamar Advertising to Reach Clinically Relevant Audiences Through Out-of-Home Healthcare Advertising

Aug 19, 2025, 7:30 AM EDT - 9 months ago

OptimizeRx Corporation Announces Leadership Team Advancements to Accelerate Strategic Growth

Aug 7, 2025, 4:30 PM EDT - 9 months ago

OptimizeRx Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:01 PM EDT - 9 months ago

OptimizeRx Reports Second Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

Jul 17, 2025, 7:30 AM EDT - 10 months ago

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET

Jun 24, 2025, 7:30 AM EDT - 11 months ago

OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

Jun 18, 2025, 3:00 AM EDT - 11 months ago

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions

May 16, 2025, 7:30 AM EDT - 1 year ago

OptimizeRx to Participate in Upcoming Investor Conferences

May 12, 2025, 4:30 PM EDT - 1 year ago

OptimizeRx Earnings Call Transcript: Q1 2025

May 12, 2025, 4:05 PM EDT - 1 year ago

OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance

May 1, 2025, 4:05 PM EDT - 1 year ago

OptimizeRx Releases 2025 Environmental, Social, and Governance (ESG) Report

Apr 23, 2025, 7:30 AM EDT - 1 year ago

OptimizeRx Sets First Quarter 2025 Conference Call for May 12, 2025, at 4:30 p.m. ET

Apr 18, 2025, 4:15 PM EDT - 1 year ago

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

Mar 12, 2025, 8:30 AM EDT - 1 year ago

OptimizeRx Earnings Call Transcript: Q4 2024

Mar 12, 2025, 7:30 AM EDT - 1 year ago

OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results

Mar 11, 2025, 7:30 AM EDT - 1 year ago

OptimizeRx Corporation Confirms Receipt of Notice of Director Nominations

Mar 10, 2025, 7:30 AM EDT - 1 year ago

OptimizeRx Corporation Appoints Stephen Silvestro as Chief Executive Officer

Feb 27, 2025, 7:30 AM EST - 1 year ago

OptimizeRx Sets Fourth Quarter and Full Year 2024 Financial Results Conference Call for March 12, 2025, at 8:30 a.m. ET

Dec 23, 2024, 8:45 AM EST - 1 year ago

OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

Nov 13, 2024, 4:30 PM EST - 1 year ago

OptimizeRx Earnings Call Transcript: Q3 2024

Oct 31, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Sets Third Quarter 2024 Conference Call for November 13, 2024 at 4:30 p.m. ET

Sep 10, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Continues to Expand its Strategic Relationship with a Top-Tier Pharma Client via a Multi-Brand, Multi-Solution Investment Commitment with Over $10M In-Year Total Value

Sep 9, 2024, 12:00 PM EDT - 1 year ago

OptimizeRx Launches Novel Brand Eligibility Technology, Enabling Dynamic Direct to Consumer Marketing for Healthcare Audiences

Aug 8, 2024, 4:30 PM EDT - 1 year ago

OptimizeRx Earnings Call Transcript: Q2 2024

Jul 25, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Sets Second Quarter 2024 Conference Call for August 8, 2024 at 4:30 p.m. ET

Jul 23, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Delivers AI-Guided Privacy-Compliant Platform for Pharmaceutical Brand Marketing Amid Evolving Consumer Privacy Legislation

Jul 15, 2024, 7:30 AM EDT - 1 year ago

OptimizeRx Demonstrates Measurable Script Lift for a Major Depressive Disorder Brand Targeting Physicians of Hard-to-Reach Patients

Jun 20, 2024, 7:30 AM EDT - 2 years ago

New White Paper Highlights How Closing the Health Information Gap Between Doctors and Patients Improves Life Science Marketing & Adds Value to Clinical Conversations

May 14, 2024, 4:30 PM EDT - 2 years ago

OptimizeRx Earnings Call Transcript: Q1 2024

May 14, 2024, 4:01 PM EDT - 2 years ago

OptimizeRx Reports First Quarter 2024 Financial Results

Apr 26, 2024, 7:30 AM EDT - 2 years ago

OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET

Apr 18, 2024, 7:30 AM EDT - 2 years ago

OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report

Apr 16, 2024, 7:00 AM EDT - 2 years ago

OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results

Apr 11, 2024, 7:30 AM EDT - 2 years ago

OptimizeRx Named America's Fastest-Growing Company for Fifth Year in a Row

Mar 28, 2024, 8:30 AM EDT - 2 years ago

OptimizeRx Earnings Call Transcript: Q4 2023

Mar 25, 2024, 7:30 AM EDT - 2 years ago

OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET

Mar 11, 2024, 4:30 PM EDT - 2 years ago

OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023

Mar 4, 2024, 3:51 PM EST - 2 years ago

OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community' Outreach Effort

Jan 25, 2024, 7:30 AM EST - 2 years ago

OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape

Jan 9, 2024, 7:30 AM EST - 2 years ago

OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update

Dec 18, 2023, 7:30 AM EST - 2 years ago

OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco

Nov 6, 2023, 8:30 AM EST - 2 years ago

OptimizeRx Earnings Call Transcript: Q3 2023

Nov 6, 2023, 7:00 AM EST - 2 years ago

OptimizeRx Reports Third Quarter 2023 Financial Results

Oct 25, 2023, 7:30 AM EDT - 2 years ago

OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET

Oct 12, 2023, 8:30 AM EDT - 2 years ago

OptimizeRx Transcript: M&A Announcement

Oct 12, 2023, 7:00 AM EDT - 2 years ago

OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers

Maissessap May. 13 at 1:44 PM

$OPRX Very well deserved drop ! Management bunch of liars.

0 · Reply

Bennettp22 May. 13 at 12:33 PM

$OPRX swing pop!! Oh yeah…

0 · Reply

MarketBeat May. 13 at 2:08 AM

https://marketbeat.com/a/8651228/ $OPRX OptimizeRx Q1 Earnings Call Highlights

0 · Reply

EarningsInsider May. 12 at 9:32 PM

https://www.marketbeat.com/earnings/reports/2026-5-12-optimizerx-co-stock/ $OPRX OptimizeRx Earnings Transcript

0 · Reply

Olivia_Strickland May. 12 at 9:09 PM

0 · Reply

Bennettp22 May. 12 at 8:45 PM

$OPRX when will I learn ….

0 · Reply

brd03 May. 12 at 8:14 PM

$OPRX earnings today??

0 · Reply

StocktwitsEarnings May. 12 at 8:14 PM

0 · Reply

MuesLee May. 12 at 7:58 PM

$OPRX $RILY $SKLZ $VELO picked oprx

1 · Reply

MuesLee May. 12 at 7:40 PM

$VELO $RILY $SKLZ $OPRX What to buy out of these four before close ... undecided yet, expect each of them to bounce and revert.

0 · Reply

dailytarget500 May. 12 at 4:06 PM

$OPRX

0 · Reply

focafoca99 May. 11 at 11:57 AM

$OPRX debuted a programmatic EHR advertising platform, letting DSPs buy point‑of‑care media at scale.

0 · Reply

dailytarget500 Apr. 29 at 12:26 PM

$OPRX

0 · Reply

souldout Apr. 29 at 11:55 AM

$OMCL Six months since IPO, MedPal AI (MPAL) is starting to look like the UK’s most interesting healthcare growth story at £14m m/c This is a UK-based, AI-powered digital health company, with Wegovy and Mounjaro licences. https://medpal.clinic/weight-loss $OPRX $LFMD

0 · Reply

Mystockbiz Apr. 22 at 12:03 AM

$OPRX

0 · Reply

Maissessap Apr. 9 at 2:43 PM

$OPRX Broken stock.

1 · Reply

focafoca99 Apr. 8 at 10:20 PM

$OPRX added Mary Varghese Presti to the board as part of its ongoing board refresh.

0 · Reply

zerodayrounder Apr. 1 at 2:48 AM

$OPRX holy shit did TrumpRx destroy this or something? Yikes.

1 · Reply

OfficialStocktwitsUser Apr. 1 at 1:59 AM

$OPRX RSI: 45.30, MACD: -0.5263 Vol: 0.48, MA20: 6.64, MA50: 8.46 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Hpad06 Mar. 31 at 5:55 PM

$OPRX it is red in a sea of green, where is the buyback

0 · Reply

dailytarget500 Mar. 25 at 4:08 PM

$OPRX

0 · Reply

Benderama8 Mar. 23 at 1:52 AM

$OPRX Is this a buy? Seems cheap down here. Can't believe this traded at 100/share. I watched it that day it touched 100.

1 · Reply

Market Cap	116.53M
Revenue (ttm)	109.43M
Net Income (ttm)	5.13M
EPS (ttm)	N/A
PE Ratio	9.61
Forward PE	12.88
Profit Margin	4.69%
Debt to Equity Ratio	0.20

Volume	656,800
Avg Vol	504,256
Day's Range	N/A - N/A
Shares Out	18.77M
Stochastic %K	38%
Beta	1.19
Analysts	Strong Sell
Price Target	$14.50